7.70
price up icon0.39%   +0.03
after-market  시간 외 거래:  7.70 
loading

Grifols SA ADR 주식(GRFS)의 최신 뉴스

It makes sense and dollars to buy Grifols SA ADR (GRFS) stock – Sete News - SETE News

pulisher
SETE News

GRFS’s Market Whiplash: -33.35% YTD Decline, 13.64% Rise in 30 Days - The InvestChronicle

pulisher
The InvestChronicle

Grifols shares fall after new Gotham City Research report - Marketscreener.com

pulisher
Marketscreener.com

A closer look at Grifols SA ADR (GRFS) is warranted – US Post News - US Post News

pulisher
US Post News

Its Stock Has Paid Off Big Time For Grifols SA ADR – Sete News - SETE News

pulisher
SETE News

Grifols 2023 Annual Report on Form 20-F filed with the SEC - PR Newswire

pulisher
PR Newswire

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

pulisher
GlobeNewswire Inc.

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper - Reuters

pulisher
Reuters

CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

pulisher
Benzinga

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

pulisher
Zacks Investment Research

Investment Opportunities in the Biopharma Industry - Morningstar

pulisher
Morningstar

Procleix ArboPlex Assay® da Grifols recebe a marca CE, o primeiro e único NAT 4 em 1 para o rastreio de arbovírus

pulisher
GlobeNewswire Inc.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

pulisher
Zacks Investment Research

Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical ... - GlobeNewswire

pulisher
GlobeNewswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS - PR Newswire

pulisher
PR Newswire

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session

pulisher
Benzinga

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

Crude Oil Falls Over 1%; Willdan Group Shares Spike Higher

pulisher
Benzinga

Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday

pulisher
Benzinga

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

pulisher
Benzinga

Grifols stock falls amid potential Moody's downgrade, new short report - Seeking Alpha

pulisher
Seeking Alpha

GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols SA (NASDAQ: GRFS) Investors with ... - GlobeNewswire

pulisher
GlobeNewswire

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Healthcare Stocks on the Move Thursday: LVTX, SCTL, ENVB, RNLX, KA, IRWD, AMPE, GRFS - InvestorsObserver

pulisher
InvestorsObserver

Grifols appoints new CEO Nacho Abia to the board - Reuters

pulisher
Reuters

Wall Street sufre un tropiezo pese al aguante de los ADR de Grifols y el 'rally' de Discover - INVERTIA

pulisher
INVERTIA

The 10 Most-Bought and Most-Sold European Stocks - Morningstar

pulisher
Morningstar

GRFS or ZTS: Which Is the Better Value Stock Right Now?

pulisher
Zacks Investment Research

Grifols announces positive topline phase 3 fibrinogen clinical trial results

pulisher
GlobeNewswire Inc.

Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now

pulisher
Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

pulisher
Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

pulisher
Zacks Investment Research

GRFS or ZTS: Which Is the Better Value Stock Right Now?

pulisher
Zacks Investment Research

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Grifols S.A. - PR Newswire

pulisher
PR Newswire

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action ... - GlobeNewswire

pulisher
GlobeNewswire

Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

GRFS vs. ZTS: Which Stock Is the Better Value Option?

pulisher
Zacks Investment Research

Delta Air Lines Reports Q4 Results, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower On Friday

pulisher
Benzinga

Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Cramer 'Takes A Pass' On Stock That's Down 31% Over Past 6 Months: 'Don't Want To Go Against Musk'

pulisher
Benzinga

Blood-plasma group’s shares rally after short seller slashes negative bet

pulisher
MarketWatch

Spain's Grifols to sue short-seller over critical report, shares jump - Reuters

pulisher
Reuters

Nasdaq Edges Higher; Cutera Shares Jump

pulisher
Benzinga

Crude Oil Gains Over 2%; TD SYNNEX Posts Downbeat Sales

pulisher
Benzinga

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Dow Tumbles Over 200 Points; US Trade Gap Narrows In November

pulisher
Benzinga

Spanish blood plasma company stock tumbles after short-seller research report

pulisher
MarketWatch
drug_manufacturers_general BMY
$44.03
price down icon 0.18%
drug_manufacturers_general GSK
$44.98
price up icon 0.22%
drug_manufacturers_general SNY
$48.67
price down icon 0.31%
drug_manufacturers_general PFE
$28.64
price down icon 0.97%
$312.47
price down icon 0.71%
drug_manufacturers_general NVS
$102.57
price down icon 0.12%
자본화:     |  볼륨(24시간):